Chemeq confirms details of $50m capital raising
Wednesday, 18 August, 2004
Chemeq (ASX: CMQ) has confirmed that its capital raising will include a placement of around AUD$10 million to institutions and sophisticated investors, as well as an underwritten rights offer of around $40 million to existing shareholders.
The placement is not likely to be completed until early next week, according to CEO Graham Melrose, and the rights issue will take another 3-4 weeks to complete. Shareholder approval is not required for the process.
Melrose said the placement price would be subject to a book building exercise, but would be likely to be in the region of $2.40-2.70.
The company is in voluntary suspension while it finalises the placement.
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
Life expectancy gains are slowing, study finds
Life expectancy at birth in the world's longest-living populations has increased by an...
Towards safer epilepsy treatment for pregnant women
New research conducted in organoids is expected to provide pregnant women with epilepsy safer...
